Schwartzmann, Benjamin
Quilty, Lena C.
Dhami, Prabhjot
Uher, Rudolf
Allen, Timothy A.
Kloiber, Stefan
Lam, Raymond W.
Frey, Benicio N.
Milev, Roumen
Müller, Daniel J.
Soares, Claudio N.
Foster, Jane A.
Rotzinger, Susan
Kennedy, Sidney H.
Farzan, Faranak
Article History
Received: 3 November 2022
Accepted: 14 May 2023
First Online: 24 May 2023
Competing interests
: T.A.A. was supported by NIMH Grant No. K01-MH123915. S.K. reports grants from the Labatt Family Innovation Fund in Brain Health (Department of Psychiatry, University of Toronto), the Max Bell Foundation, the Canadian Centre on Substance Use and Addiction, the Ontario Ministry of Health and Long-Term Care (MOHLTC), and the Canadian Institutes of Health Research (CIHR). S.K. has received honorarium for past consultation from EmpowerPharm. R.W.L. has received honoraria for ad hoc speaking or advising/consulting, or received research funds, from: Asia–Pacific Economic Cooperation, BC Leading Edge Foundation, Canadian Institutes of Health Research, Canadian Network for Mood and Anxiety Treatments, Grand Challenges Canada, Healthy Minds Canada, Janssen, Lundbeck, Lundbeck Institute, Medscape, Michael Smith Foundation for Health Research, MITACS, Myriad Neuroscience, Ontario Brain Institute, Otsuka, Pfizer, Sanofi, Unity Health, Vancouver Coastal Health Research Institute, and VGH-UBCH Foundation. R.M. has received consulting and speaking honoraria from AbbVie, Allergan, Eisai, Janssen, KYE, Lallemand, Lundbeck, Neonmind, Otsuka, and Sunovion, and research grants from CAN-BIND, CIHR, Janssen, Lallemand, Lundbeck, Nubiyota, OBI and OMHF. C.N.S. reported receiving personal fees from Otsuka and Sunovion and grants from Ontario Brain Institute, SEAMO Innovation Funds, and Ontario Research Fund–Research Excellence outside the submitted work. J.A.F. reported consulting fees from RBH Inc and Takeda Canada. S.R. reported receiving grants from Ontario Brain Institute and the Canadian Institutes of Health Research during the conduct of the study and having a patent to Teneurin C-Terminal Associated Peptides and Methods and Uses Thereof issued. S.H.K.—Grant received/grants pending—Abbott, Allergan, Brain Canada, Canadian Institutes for Health Research (CIHR), Janssen, Lundbeck, Ontario Brain Institute, Ontario Research Fund (ORF), Otsuka, Pfizer, Servier, Sunovion and Xian-Janssen. Consulting fees or honorarium—Abbott, Alkermes, Allergan, Boehringer Ingelheim, Brain Canada, Canadian Institutes for Health Research (CIHR), Janssen, Lundbeck, Lundbeck Institute, Ontario Brain Institute, Ontario Research. Stock/Stock Options – Field Trip Health. F.F. reported received funding from Michael Smith Foundation for Health Research, Natural Sciences and Engineering Research Council of Canada Discovery, and Canadian Institutes of Health Research. All other authors report no biomedical financial interests or potential conflicts of interest.